23 November 2001 News Update
ALLERGY TREATMENT FUNDED
Another allergy treatment for hayfever sufferers will be fully funded on the Pharmaceutical Schedule from February 2002.
Pharmac has awarded a tender to Pacific Pharmaceuticals for the non-sedating histamine, loratadine (Lora-tabs).
Pharmac medical director Dr Peter Moodie said the decision will free up more than $1 million over two and a half years.
Back to welcome page
Back to news archives
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
Click here to find out who the winners are for the Pharmacy Today/Zuellig Pharma Pharmacy Awards 2002. Also view and purchase photos of the Awards.
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
Consumer Health Information
New Zealand Doctor Online
Home II Conferences II Contact Us II Continuing Education II Magazine Profile II Monthly News Archives
Weekly News Archives II II Readership II Search Magazine Archives II Submit a Classified Advertisement